Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Low Risk Differentiated Thyroid Cancer × Thyrotropin Alfa × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Neoplasms 9 Thyroid Cancer, Papillary 3 Differentiated Thyroid Cancer 3 Adenocarcinoma, Follicular 3 Recombinant Human Thyroid Stimulating Hormone 1 Neoplasm Metastasis 1 Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation 1 Low Risk Differentiated Thyroid Cancer 1 Hypothyroidism 1 Heterotaxy Syndrome 1 DTC - Differentiated Thyroid Cancer 1

Interventions

Thyrotropin Alfa 1 Iodine-131 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01837745 2023-05-17

ESTIMABL2

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting

EndocrineHead & Neck

Low Risk Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡